Literature DB >> 9228591

Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

D M Patrick1, S A Strathdee, C P Archibald, M Ofner, K J Craib, P G Cornelisse, M T Schechter, M L Rekart, M V O'Shaughnessy.   

Abstract

To identify determinants of HIV seroconversion among injection drug users (IDUs) during a period of rising prevalence, a case-control investigation was conducted. Cases were IDUs with a new positive test after 1 January 1994, and a negative test within the prior 18 months. Controls required 2 negative tests during the same period. Subjects completed a questionnaire on demographic, psychosocial, and behavioural factors. Eighty-nine cases and 192 controls were similar with respect to gender, age, ethnicity and inter-test interval. Multivariate analyses of events during the inter-test interval showed borrowing syringes (adj. OR = 2.96; P < 0.006), unstable housing (adj. OR = 2.01; P = 0.03) and injecting > or = 4 times daily (adj. OR = 1.71; P = 0.06) to be independently associated with seroconversion. Protective associations were demonstrated for sex with opposite gender (adj. OR = 0.36; P = 0.001) and tetrahydrocannabinol use (adj. OR = 0.41; P = 0.001). There is a need to evaluate programmes dealing with addiction, housing and the social underpinnings of risk behaviours in this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228591     DOI: 10.1258/0956462971920497

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  37 in total

1.  Sex-specific determinants of HIV infection among injection drug users in Montreal.

Authors:  J Bruneau; F Lamothe; J Soto; N Lachance; J Vincelette; A Vassal; E L Franco
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Harmful microinjecting practices among a cohort of injection drug users in vancouver Canada.

Authors:  Beth Rachlis; Elisa Lloyd-Smith; Will Small; Diane Tobin; Dave Stone; Kathy Li; Evan Wood; Thomas Kerr
Journal:  Subst Use Misuse       Date:  2010-07       Impact factor: 2.164

Review 3.  Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.

Authors:  Michael V O'Shaughnessy; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

4.  Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis.

Authors:  Sophie Patterson; Angela Kaida; Paul Nguyen; Sabina Dobrer; Gina Ogilvie; Robert Hogg; Thomas Kerr; Julio Montaner; Evan Wood; M-J Milloy
Journal:  CMAJ Open       Date:  2016-04-28

Review 5.  The urban environment and sexual risk behavior among men who have sex with men.

Authors:  Victoria Frye; Mary H Latka; Beryl Koblin; Perry N Halkitis; Sara Putnam; Sandro Galea; David Vlahov
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

6.  Syringe Sharing Among a Prospective Cohort of Street-Involved Youth: Implications for Needle Distribution Programs.

Authors:  Nikki Bozinoff; Evan Wood; Huiru Dong; Lindsey Richardson; Thomas Kerr; Kora DeBeck
Journal:  AIDS Behav       Date:  2017-09

7.  Supervised injection sites: prejudice should not trump evidence of benefit.

Authors:  Maria Zlotorzynska; Evan Wood; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2013-09-16       Impact factor: 8.262

8.  Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.

Authors:  Anna L Hotton; Basmattee Boodram
Journal:  AIDS Behav       Date:  2017-04

Review 9.  Women who use injection drugs: the social context of risk.

Authors:  E M Whynot
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

10.  Barriers to practicing risk reduction strategies among people who inject drugs.

Authors:  Kristina T Phillips
Journal:  Addict Res Theory       Date:  2015-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.